Pick Your Community: | Hopkins | Muhlenberg | Daviess | Christian | Henderson | Lakes | McCracken | Webster

FDA Approves New Drug for Advanced Prostate Cancer

fda2WASHINGTON, D.C. (5/15/13) - The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. It is intended for men whose cancer has spread after receiving medical or surgical therapy to lower testosterone.

Prostate cancer forms in a gland in the male reproductive system found below the bladder and in front of the rectum. The male sex hormone testosterone stimulates the prostate tumors to grow. According to the National Cancer Institute, an estimated 238,590 men will be diagnosed with prostate cancer and 29,720 will die from the disease in 2013.

Xofigo is being approved more than three months ahead of the product’s prescription drug user fee goal date of Aug. 14, 2013, the date the agency was scheduled to complete review of the drug application. The FDA reviewed Xofigo under the agency’s priority review program, which provides for an expedited review of drugs that appear to provide safe and effective therapy when no satisfactory alternative therapy exists, or offer significant improvement compared to marketed products.

“Xofigo binds with minerals in the bone to deliver radiation directly to bone tumors, limiting the damage to the surrounding normal tissues,” said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research. “Xofigo is the second prostate cancer drug approved by the FDA in the past year that demonstrates an ability to extend the survival of men with metastatic prostate cancer.”

In August 2012, the FDA approved Xtandi to treat men with metastatic castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone. Xtandi is approved for patients who have previously been treated the chemotherapy drug docetaxel.

Xofigo’s safety and effectiveness were evaluated in a single clinical trial of 809 men with symptomatic castration-resistant prostate cancer that spread to bones but not to other organs. Patients were randomly assigned to receive Xofigo or a placebo plus best standard of care.

The study was designed to measure overall survival. Results from a pre-planned interim analysis showed men receiving Xofigo lived a median of 14 months compared to a median of 11.2 months for men receiving placebo. An exploratory updated analysis conducted later in the trial confirmed Xofigo’s ability to extend overall survival.

The most common side effects reported during clinical trials in men receiving Xofigo were nausea, diarrhea, vomiting and swelling of the leg, ankle or foot. The most common abnormalities detected during blood testing included low levels of red blood cells (anemia), lymphocytes (lymphocytopenia), white blood cells (leukopenia), platelets (thrombocytopenia) and infection-fighting white blood cells (neutropenia).

Xofigo is marketed by Wayne, N.J.-based Bayer Pharmaceuticals. Xtandi is co-marketed by Astellas Pharma U.S., Inc. of Northbrook, Ill., and Medivation, Inc. of San Francisco, Calif.
 
SurfKY News
Information provided by the United States Food and Drug Administration

© Copyright 2014 SurfKY News Group, Inc. All rights reserved. This material may not be published, broadcast, or rewritten without permission. SurfKY News encourages you to share this story by using one of the social media links below.

button coupons
button classifieds

In Other News...

Southtown Boulevard Extension Open

OWENSBORO, Ky. (11/26/14) — The Southtown Boulevard extension to the Airpark (across Carter Road) will open to traffic… Read More

Owensboro Convention Center Partners with Kentucky Proud to Promote Locally Sourced Foods

OWENSBORO, Ky. (11/25/14) — In cooperation with the Kentucky Department of Agriculture, Global Spectrum, operators of… Read More

Most Read This Week

November 21, 2014 7000

Man Accused of Assaulting Coach During Basketball…

in Local (Muhlenberg) Top News by Rita Dukes Smith, SurfKY News Director
November 22, 2014 4681

One Injured in Two Vehicle Collision in Greenville

in Local (Muhlenberg) Top News by Miria Thomas
November 21, 2014 4389

Crashing Dump Trucks in Work Zone Cause Pennyrile…

in Top News For All Sites Touching Hopkins by Trooper Stu Recke
November 21, 2014 3626

Muhlenberg District Court Fines Handed Down

in Local (Muhlenberg) Top News by Charles W. Riley II, SurfKY News
November 21, 2014 3429

Madisonville Police Arrest Reports - Nov. 21, 2014

in Hopkins News by Madisonville Police Department
November 21, 2014 2996

Swimming and Diving Closes Fall Season at Ohio…

in General Sports For All Sites by UK Athletics
November 24, 2014 2827

Two Charged for Possession of Meth After…

in Local (Muhlenberg) Top News by MCSO/PIO Alex Piper
November 20, 2014 2648

Local Church Prepares for 'Return to Bethlehem'

in Video by Gary Gates, SurfKY News
November 21, 2014 2610

Kentucky Employers to Save About $112 million

in General News For All Sites by Cathy Lindsey
November 20, 2014 2597

Madisonville Police Arrest Reports - Nov. 20, 2014

in Hopkins News by Madisonville Police Department

Stories Trending Today

November 25, 2014 2413

Madisonville Man Charged for Selling Cocaine

in Local (Hopkins) Top News by Madisonville Police Department
November 25, 2014 2266

Call for Help Results in Arrest for Possession of…

in Local (Hopkins) Top News by Madisonville Police Department
November 25, 2014 1513

Madisonville Police Arrest Reports - Nov. 25, 2014

in Hopkins News by Madisonville Police Department
November 25, 2014 1505

Slow Cook a Turkey for a Tasty Thanksgiving Feast

in General News For All Sites by SurfKY News
November 25, 2014 1429

Protect Your Home When Traveling This Holiday…

in General News For All Sites by SurfKY News
November 24, 2014 1311

KSP Post 2 Thanksgiving Holiday Enforcement…

in Top News For All Sites Touching Hopkins by Trooper S. C. Recke
November 25, 2014 1240

Muhlenberg Job Corps Recognizes Employee of the…

in Local (Muhlenberg) Top News by Karen Robinson
November 25, 2014 1144

Construction Projects Suspended to Ease Holiday…

in General News For All Sites by Lisa Tolliver
November 25, 2014 1006

Parking Committee 2015 Meeting Schedule

in Owensboro News by Beth Cecil
November 25, 2014 931

Bake Sale Held for Two Year-Old Burn Victim

in Local (Hopkins) Top News by Tammy Holloway, SurfKY News

SurfKY News Group, Inc.
Corporate Office & Studio
1125 Nebo Rd.  •  Madisonville, KY 42431
270.452.2727 (phone)
  •  270.452.2249 (fax)


Contact a member of our staff: www.surfky.com/contact
Copyright © 2014 SurfKY News Group, Inc.  •  Terms of Use  •  Site Map

social fbsocial twsocial yt
social gpsocial flrsocial rss